Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 7/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 0.76 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.71 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.71 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.71 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.71 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.71 |
| ▸ | BRD4 | O60885 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | CNR1 | P21554 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.54 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | GABRP | O00591 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adinazolam SCHEMBL29358737 | 1.00 | OPRK1 (1.00) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| Adinazolam SCHEMBL123268 | 0.93 | OPRK1 (0.87) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| Adinazolam SCHEMBL7325958 | 0.92 | OPRK1 (0.85) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL11606370 | 0.92 | OPRK1 (0.84) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL11863331 | 0.91 | OPRK1 (0.84) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL11346962 | 0.91 | OPRK1 (0.83) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL7327610 | 0.89 | OPRK1 (0.81) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL11349548 | 0.89 | OPRK1 (0.81) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL7321230 | 0.89 | OPRK1 (0.80) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL7434031 | 0.88 | OPRK1 (0.79) | OPRK1HPGDGABRA1GABRA5GABRA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5466 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076953-A1 | METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-03-19 | — | — | US | claimed |
| US-20250179064-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS LLC | 2025-06-05 | — | — | US | claimed |
| US-20250120962-A1 | NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2025-04-17 | — | — | US | claimed |
| EP-4023222-B1 | NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR FOR TREATMENT OF 22Q SYNDROME | CHILDRENS HOSPITAL PHILADELPHIA (US) | 2024-12-18 | — | — | EP | claimed |
| US-20240307386-A1 | NOVEL METHODS | INTRA-CELLULAR THERAPIES, INC. | 2024-09-19 | — | — | US | claimed |
| US-20240277697-A1 | METHODS OF TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH OPIATE WITHDRAWAL OR OPIATE RELAPSE | PRONIRAS CORPORATION | 2024-08-22 | — | — | US | claimed |
| US-20240277696-A1 | METHODS OF TREATING NERVE AGENT-INDUCED SEIZURES | PRONIRAS CORPORATION | 2024-08-22 | — | — | US | claimed |
| US-20240238250-A1 | METHOD OF USING PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2024-07-18 | — | — | US | claimed |
| WO-2024150170-A1 | PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2024-07-18 | — | — | WO | claimed |
| US-20240189295-A1 | NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2024-06-13 | — | — | US | claimed |
| EP-0146306-A1 | Adinazolam methanesulfonate | THE UPJOHN COMPANY (US) | 1985-06-26 | — | — | EP | claimed |
| US-4501698-A | REACTION WITH PARAFORMALDEHYDE, SULFONYL HALIDE, AMINO COMPOUND | THE UPJOHN COMPANY (US) | 1985-02-26 | — | — | US | claimed |
| EP-0127417-A1 | Process for preparing 1-dimethylaminomethyl-triazolobenzodiazepines | THE UPJOHN COMPANY (US) | 1984-12-05 | — | — | EP | claimed |
| EP-0121375-A1 | Processes for preparing 1-(hydroxymethyl)triazolobenzodiazepines and 1-(aminomethyl)triazolobenzodiazepines | THE UPJOHN COMPANY (US) | 1984-10-10 | — | — | EP | claimed |
| US-4474699-A | Preparing 1-aminomethyl-6-substituted-4H-s-triazolo[4,3-a][1,4]benzodiazepines in improved procedures | THE UPJOHN COMPANY (US) | 1984-10-02 | — | — | US | claimed |
| US-4472397-A | Use of certain 1-substituted-triazolo-benzodiazepines to treat psychoses | THE UPJOHN COMPANY (US) | 1984-09-18 | — | — | US | claimed |
| EP-0117140-A1 | Triazolobenzodiazepines for anti-psychotic use | THE UPJOHN COMPANY (US) | 1984-08-29 | — | — | EP | claimed |
| US-4264615-A | ANTIDEPRESSANTS | THE UPJOHN COMPANY (US) | 1981-04-28 | — | — | US | claimed |
| US-4250094-A | SEDATIVES, TRANQUILIZERS, MUSCLE RELAXANTS, AND ANTIDEPRESSANTS | THE UPJOHN COMPANY (US) | 1981-02-10 | — | — | US | claimed |
| US-4001262-A | Process for the production of 1-[(dimethylamino)methyl]-6-phenyl-4H-triazolo[4,3-a][1,4]-benzodiazepine | THE UPJOHN COMPANY (US) | 1977-01-04 | — | — | US | claimed |